| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11642355 | SLAYBACK PHARMA LLC | Pharmaceutical compositions of testosterone |
Mar, 2039
(14 years from now) | |
| US11311554 | SLAYBACK PHARMA LLC | Pharmaceutical compositions of testosterone |
Mar, 2039
(14 years from now) | |
Testosterone Cypionate is owned by Slayback Pharma Llc.
Testosterone Cypionate contains Testosterone Cypionate.
Testosterone Cypionate has a total of 2 drug patents out of which 0 drug patents have expired.
Testosterone Cypionate was authorised for market use on 02 June, 2022.
Testosterone Cypionate is available in solution;intramuscular dosage forms.
The generics of Testosterone Cypionate are possible to be released after 25 March, 2039.
Drugs and Companies using TESTOSTERONE CYPIONATE ingredient
Market Authorisation Date: 02 June, 2022
Treatment: NA
Dosage: SOLUTION;INTRAMUSCULAR
More Information on Dosage
TESTOSTERONE CYPIONATE family patents
